For over 15 years, Peter Frantz has worked with clients in clinical trial research and regulated product development. He is responsible for all business operations activities at Amarex Clinical Research, an NSF International company, including business development, corporate accounting, financial planning, business planning and contracting. His experience includes project management of domestic and international trials, day-to-day management of lead drug candidates, strategic planning for new medical products and investor relations. Mr. Frantz previously worked in a variety of positions with companies ranging from small biopharmaceutical organizations to large government consulting firms. He earned a master's degree in biochemistry and molecular biology with a specialization in biotechnology, as well as an Executive MBA, from Georgetown University.